☰

Michael Donohue, Ph.D. - Publications

Affiliations: 
2005 University of California, San Diego, La Jolla, CA 
Area:
Mathematics
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Suzuki K, Hirakawa A, Ihara R, Iwata A, Ishii K, Ikeuchi T, Sun CK, Donohue M, Iwatsubo T. Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 6: e12007. PMID 32211510 DOI: 10.1002/Trc2.12007  0.334
2019 Mattsson N, Insel PS, Donohue M, Jögi J, Ossenkoppele R, Olsson T, Schöll M, Smith R, Hansson O. Predicting diagnosis and cognition with F-AV-1451 tau PET and structural MRI in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30639421 DOI: 10.1016/J.Jalz.2018.12.001  0.319
2015 Aisen PS, Petersen RC, Donohue M, Weiner MW. Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 734-9. PMID 26194309 DOI: 10.1016/J.Jalz.2015.05.005  0.352
2015 Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. Jama Neurology. 72: 554-60. PMID 25775167 DOI: 10.1001/Jamaneurol.2014.4530  0.325
2015 Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Brain : a Journal of Neurology. 138: 772-83. PMID 25541191 DOI: 10.1093/Brain/Awu367  0.339
2014 Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Annals of Clinical and Translational Neurology. 1: 534-43. PMID 25356425 DOI: 10.1002/Acn3.81  0.318
2014 Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen P. The A4 study: stopping AD before symptoms begin? Science Translational Medicine. 6: 228fs13. PMID 24648338 DOI: 10.1126/Scitranslmed.3007941  0.341
2014 Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain : a Journal of Neurology. 137: 1550-61. PMID 24625697 DOI: 10.1093/Brain/Awu043  0.301
2013 Jack C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P, Shaw L, Vemuri P, Wiste H, Weigand S, Lesnick T, Pankratz V, Donohue M, Trojanowski J. O3-03-01: Update on hypothetical model of Alzheimer's disease biomarkers Alzheimer's & Dementia. 9: P521-P522. DOI: 10.1016/J.Jalz.2013.04.248  0.303
2012 Vellas B, Hampel H, Rougé-Bugat ME, Grundman M, Andrieu S, Abu-Shakra S, Bateman R, Berman R, Black R, Carrillo M, Donohue M, Mintun M, Morris J, Petersen R, Thomas RG, et al. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. The Journal of Nutrition, Health & Aging. 16: 339-45. PMID 22499454 DOI: 10.1007/S12603-012-0044-X  0.348
2012 Sperling R, Downing AC, Salmon D, Rentz D, Siemers E, Sethuraman G, Karlawish J, Johnson K, Donohue M, Aisen P. The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease Alzheimers & Dementia. 10: 246. DOI: 10.1016/J.Jalz.2014.04.378  0.32
2012 Burns L, Rueckert D, Bhagwagar Z, Donohue M, Wolz R, Tiller J, Soares H, l'Italien G, Coric V, Hayes W, Fox N, Berman R. A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 8: 408. DOI: 10.1016/J.Jalz.2012.05.2037  0.322
2012 Donohue M, Aisen P, Dartigues J, Jacqmin-Gadda H, Gamst A, Goff ML. Validating Alzheimer's pathological cascade by merging ADNI with PAQUID Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1636  0.327
2011 Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, Hendrix SB, Grundman M, Schneider LS, Schindler RJ, Salmon E, ... ... Donohue M, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 76: 280-6. PMID 21178097 DOI: 10.1212/Wnl.0B013E318207B1B9  0.338
2011 Burns L, Berman R, Guo Z, Soares H, Kaplita S, Yoo B, Donohue M. The relationship between cerebral spinal fluid (CSF) biomarkers and Pittsburgh Compound B (PiB) positron emission tomography (PET) in predicting Alzheimer's disease (AD) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.579  0.301
2011 Sano M, Egelko S, Ferris S, Kaye J, Hayes T, Mundt J, Reyes T, Donohue M, Sun C, Whitehair D, Stokes K, Aisen P. Alzheimer disease cooperative study (ADCS) home based assessment: Designing trials with new technology Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1434  0.309
2010 Lorenzi M, Donohue M, Paternicò D, Scarpazza C, Ostrowitzki S, Blin O, Irving E, Frisoni GB. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment. Neurobiology of Aging. 31: 1443-51, 1451.e1. PMID 20541287 DOI: 10.1016/J.Neurobiolaging.2010.04.036  0.32
2010 Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, Kuo JH. The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 257-64. PMID 20451874 DOI: 10.1016/J.Jalz.2010.03.002  0.363
2009 Fleisher AS, Donohue M, Chen K, Brewer JB, Aisen PS. Applications of neuroimaging to disease-modification trials in Alzheimer's disease. Behavioural Neurology. 21: 129-36. PMID 19847051 DOI: 10.3233/Ben-2009-0241  0.371
2009 Donohue M, Gamst A, Aisen P. Designing Early (pre-dementia) Alzheimer's Disease Trials: Linear Mixed Models Versus Time To Conversion Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.07.084  0.356
2008 Donohue M, Abramson I, Gamst A. Asynergistic regression based on maximized rank correlation Communications in Statistics: Simulation and Computation. 37: 92-105. DOI: 10.1080/03610910701723716  0.539
2008 Petersen RC, Aisen P, Beckett L, Donohue M, Weng Q, Salmon D, Weiner M. P3-040: Alzheimer's disease neuroimaging initiative: Baseline characteristics Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1603  0.329
Show low-probability matches.